SCHEMBL25015920

SCHEMBL25015920

COc1ccc(CNc2ncnc3c2c(-c2ccn(C)n2)cn3[C@H]2CC(O[Si](C)(C)C(C)(C)C)[C@@H](C)C2)c(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 3/20 0.38
▸ CYP1A2 P05177 15/20 0.37
▸ CYP3A4 P08684 15/20 0.37
▸ CYP2C19 P33261 15/20 0.37
▸ TSHR P16473 13/20 0.37
▸ CYP2D6 P10635 13/20 0.37
▸ ALDH1A1 P00352 10/20 0.37
▸ CYP2C9 P11712 8/20 0.37
▸ MAPK1 P28482 5/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CLK4 Q9HAZ1 8/20 0.37
▸ USP2 O75604 5/20 0.37
▸ HSD17B10 Q99714 8/20 0.37
▸ ALOX15 P16050 5/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ PRMT5 O14744 2/20 0.37
▸ WDR77 Q9BQA1 2/20 0.37
▸ LMNA P02545 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016861 0.91 METTL3 (0.39) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772286 0.91 METTL3 (0.39) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL23313891 0.91 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772302 0.91 METTL3 (0.36) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL30106842 0.91 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772290 0.91 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772309 0.88 CYP1A2 (0.38) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL25016859 0.88 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL23273903 0.88 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL29772283 0.88 METTL3 (0.37) METTL3CYP1A2CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027361-A1 METTL3 MODULATORS ACCENT THERAPEUTICS, INC. (US) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027361-A1 METTL3 MODULATORS METTL3, METTL16, METTL14 METTL3 1/4885CYP1A2 989/4885CYP3A4 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback